Allergic Rhinitis

Key Points

  • Allergic rhinitis is a localized IgE-mediated reaction of nasal mucosa triggered by inhaled or ingested allergens.
  • Histamine-driven vasodilation and capillary leak cause edema, congestion, itching, sneezing, and watery drainage.
  • Seasonal patterns commonly follow tree pollen (spring), grass pollen (summer), and weed pollen (fall).
  • Diagnosis requires symptom history plus exam and testing; skin-test results should not be used in isolation because false positives/negatives occur.
  • Nursing priorities are trigger reduction, adherence coaching, respiratory monitoring, and early escalation for severe reactions.
  • Allergen immunotherapy may be used when avoidance is not feasible and can require years of sustained treatment.

Pathophysiology

Allergic rhinitis develops after sensitization to allergens, followed by re-exposure that activates an IgE-mediated inflammatory cascade in nasal mucosa. Histamine is a major mediator and contributes to vasodilation, increased capillary permeability, tissue edema, and mucosal congestion.

Symptoms can be seasonal or persistent depending on local allergen exposure. Common manifestations include congestion, sneezing, pruritus of nose/throat, watery rhinorrhea, postnasal drip, and itchy/watery eyes. Chronic uncontrolled symptoms can impair sleep, school/work performance, and overall quality of life.

Seasonal Pattern Snapshot

  • Early spring: Tree pollen (for example elm, poplar, oak)
  • Early summer: Grass pollen (for example redtop, timothy)
  • Early fall: Weed pollen (for example ragweed)

Nursing Assessment

NCLEX Focus

Prioritize airway-breathing cues and progression risk (wheezing, dyspnea, voice change, edema) before comfort-only symptoms.

  • Assess timing/seasonality of symptoms, suspected triggers, and prior treatment response.
  • Assess congestion severity, nasal/throat itch, sneezing pattern, rhinorrhea, sleep disruption, headache, and postnasal drip.
  • Obtain personal/family allergy history and medication history, including adherence barriers.
  • Screen for associated conditions (for example asthma, sinusitis, conjunctivitis) and emotional distress that may worsen symptoms.
  • Review diagnostic context: peripheral blood count, eosinophils, total/specific IgE, and skin-test findings interpreted with history and exam.

Nursing Interventions

  • Reduce exposure by environmental control measures (air filtration, bedding hygiene, dust reduction, smoke-free spaces, shower/change clothes after outdoor exposure).
  • Reinforce medication-purpose distinctions (maintenance versus rescue symptom relief) and schedule adherence.
  • Teach proper self-administration technique for prescribed nasal/oral therapies and expected onset timing.
  • Monitor respiratory status and pulse pattern; keep emergency medications/equipment available for severe reactions.
  • In selected patients with positive allergy history/testing and limited trigger-avoidance options, reinforce long-horizon immunotherapy adherence (often multi-year treatment).
  • For subcutaneous immunotherapy pathways, monitor for at least 30 minutes after injections and report large local swelling before dose escalation.
  • Reinforce pregnancy safety context: avoid initiating immunotherapy during pregnancy, and avoid dose increases if therapy was already in progress.
  • Provide discharge education on trigger minimization, follow-up timing, and return precautions.

Escalation Trigger

New wheezing, dyspnea, dysphagia, angioedema, or generalized urticaria requires urgent reassessment for evolving severe allergic reaction.

Pharmacology

Drug ClassExamplesKey Nursing Considerations
decongestantsPseudoephedrine, phenylephrineShort-course use; monitor BP, palpitations, and rebound congestion with prolonged topical use.
antihistaminesDiphenhydramine, cetirizine, loratadineEarly dosing at symptom onset can improve control; first-generation agents increase sedation and anticholinergic risk.
mast-cell-stabilizersCromolyn intranasalPreventive use; not a rescue option and effect may take days.
corticosteroidsTriamcinolone, budesonide, beclomethasoneUseful in more severe or persistent rhinitis; reinforce consistent technique and infection-risk monitoring.
leukotriene-receptor-antagonistsMontelukast, zafirlukastLong-term anti-inflammatory role; not for acute rescue symptoms.
allergen-immunotherapySIT, EPIT, SLITConsider when allergen avoidance is not feasible; monitor systemic-reaction risk and long-term adherence.

Clinical Judgment Application

Clinical Scenario

A patient presents in early spring with recurrent sneezing, severe nasal congestion, itchy watery eyes, and poor sleep despite intermittent OTC medication use.

  • Recognize Cues: Seasonal recurrence, uncontrolled nasal/ocular symptoms, and sleep-related functional decline.
  • Analyze Cues: Pattern supports poorly controlled allergic rhinitis with ongoing allergen exposure and inconsistent regimen use.
  • Prioritize Hypotheses: Priority is symptom control with prevention of respiratory complications and adherence failure.
  • Generate Solutions: Combine trigger-reduction coaching with scheduled maintenance therapy and clear rescue-symptom guidance.
  • Take Action: Implement education, verify technique, reinforce follow-up, and monitor for escalation signs.
  • Evaluate Outcomes: Congestion and sneezing decrease, sleep improves, and the patient correctly explains medication and escalation plan.

Self-Check

  1. Why should skin-test findings be interpreted with history and examination rather than alone?
  2. Which findings in allergic rhinitis suggest urgent escalation beyond routine symptom management?
  3. How do you teach the difference between maintenance and rescue medication use in allergy care?